Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 65
- +15 vs. Q2 2022
- Portfolio value
- $564.7M
- +$37.8M (+7.2%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 897,060 | $49.2M | 8.7% | +98,450+12.3% | Added | History |
| LLYEli Lilly & Co | Stock | 143,550 | $46.4M | 8.2% | +11,300+8.5% | Added | History |
| SNYSanofi | SPONSORED ADR | 1,214,515 | $46.2M | 8.2% | +368,300+43.5% | Added | History |
| JNJJohnson & Johnson | Stock | 216,151 | $35.3M | 6.3% | −60,300−21.8% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 367,000 | $31.6M | 5.6% | +82,000+28.8% | Added | History |
| NVONovo Nordisk A S | ADR | 296,440 | $29.5M | 5.2% | +35,000+13.4% | Added | History |
| ABBVAbbVie Inc. | Stock | 162,285 | $21.8M | 3.9% | −56,100−25.7% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 822,696 | $19.8M | 3.5% | −316,633−27.8% | Reduced | History |
| BIIBBiogen Inc. | COM | 55,500 | $14.8M | 2.6% | +55,500 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 626,552 | $12.3M | 2.2% | +39,732+6.8% | Added | History |
| KURAKura Oncology, Inc. | COM | 789,952 | $10.8M | 1.9% | +295,357+59.7% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,245,806 | $10.7M | 1.9% | +946,152+315.7% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 534,358 | $10.5M | 1.9% | −109,373−17.0% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 581,829 | $10.4M | 1.8% | −380,641−39.5% | Reduced | History |
| PANWPalo Alto Networks Inc | Stock | 63,000 | $10.3M | 1.8% | +63,000 | New | History |
| WIXWix.com Ltd. | SHS | 129,000 | $10.1M | 1.8% | +129,000 | New | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 301,625 | $8.61M | 1.5% | −235,039−43.8% | Reduced | History |
| KRNTKornit Digital Ltd. | SHS | 322,926 | $8.59M | 1.5% | +322,926 | New | History |
| GLBEGlobal-E Online Ltd. | SHS | 311,460 | $8.34M | 1.5% | +311,460 | New | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,052,842 | $8.14M | 1.4% | +1,052,842 | New | History |
| ADBEAdobe Inc. | Stock | 29,150 | $8.02M | 1.4% | +29,150 | New | History |
| IMTXImmatics N.V. | SHS | 795,406 | $7.95M | 1.4% | +64,694+8.9% | Added | History |
| PERIPerion Network Ltd. | SHS NEW | 405,184 | $7.82M | 1.4% | +405,184 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 206,819 | $7.78M | 1.4% | +138,822+204.2% | Added | History |
| ALTAltimmune, Inc. | COM NEW | 600,298 | $7.67M | 1.4% | −792,586−56.9% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 173,696 | $7.19M | 1.3% | +173,696 | New | History |
| SSentinelOne, Inc. | CL A | 280,000 | $7.16M | 1.3% | +280,000 | New | History |
| RLMDRelmada Therapeutics, Inc. | COM | 193,230 | $7.15M | 1.3% | −273,600−58.6% | Reduced | History |
| ALBOAlbireo Pharma, Inc. | COM | 359,000 | $6.95M | 1.2% | +359,000 | New | History |
| SEDGSolaredge Technologies, Inc. | COM | 29,426 | $6.81M | 1.2% | +29,426 | New | History |
| GILDGilead Sciences, Inc. | Stock | 105,090 | $6.48M | 1.1% | +105,090 | New | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 952,783 | $6.38M | 1.1% | +273,383+40.2% | Added | History |
| MRUSMerus N.V. | COM | 313,326 | $6.28M | 1.1% | −95,835−23.4% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 334,080 | $6.27M | 1.1% | +334,080 | New | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 776,346 | $6.26M | 1.1% | −371,532−32.4% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 464,860 | $4.91M | 0.9% | +464,860 | New | – |
| NVDANVIDIA Corp | Stock | 40,000 | $4.86M | 0.9% | +28,712+254.4% | Added | History |
| CINCCinCor Pharma, Inc. | COM | 118,950 | $3.90M | 0.7% | +118,950 | New | History |
| Fiverr Intl Ltd33835LAA3 | NOTE 11/0 | 4,951,000 | $3.90M | 0.7% | 00.0% | Unchanged | – |
| ETNB89bio, Inc. | COM | 658,784 | $3.81M | 0.7% | +208,784+46.4% | Added | History |
| RZLTRezolute, Inc. | COM NEW | 1,155,897 | $3.17M | 0.6% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 1,175,058 | $3.15M | 0.6% | +9,458+0.8% | Added | History |
| DICEDICE Therapeutics, Inc. | COM | 152,913 | $3.10M | 0.5% | +152,913 | New | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $2.83M | 0.5% | +29,807+5.0% | Added | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 2,162,586 | $2.55M | 0.5% | −362,414−14.4% | Reduced | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 187,800 | $2.23M | 0.4% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 157,200 | $2.02M | 0.4% | +157,200 | New | History |
| RUNSunrun Inc. | COM | 65,000 | $1.79M | 0.3% | +65,000 | New | History |
| INFIInfinity Pharmaceuticals, Inc. | COM | 1,476,000 | $1.76M | 0.3% | +1,476,000 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 200,000 | $1.44M | 0.3% | +200,000 | New | History |
| Magic Software Enterprises L559166103 | ORD | 81,293 | $1.26M | 0.2% | 00.0% | Unchanged | – |
| VRNAVerona Pharma plc | SPONSORED ADS | 120,000 | $1.23M | 0.2% | +120,000 | New | History |
| PSTXPoseida Therapeutics, Inc. | COM | 300,000 | $1.06M | 0.2% | +300,000 | New | History |
| MDWDMediWound Ltd. | ORD SHS | 688,716 | $958.0K | 0.2% | +688,716 | New | History |
| ICLICL Group Ltd. | SHS | 111,482 | $912.0K | 0.2% | +111,482 | New | History |
| NICENICE Ltd. | SPONSORED ADR | 3,145 | $592.0K | 0.1% | −52,337−94.3% | Reduced | History |
| Wix.com Ltd.92940WAD1 | NOTE 8/1 | 700,000 | $591.0K | 0.1% | 00.0% | Unchanged | – |
| EWTXEdgewise Therapeutics, Inc. | COM | 60,000 | $590.0K | 0.1% | +60,000 | New | History |
| Nice Sys Inc65366HAB9 | NOTE 1.250% 1/1 | 250,000 | $571.0K | 0.1% | 00.0% | Unchanged | – |
| ONCROncorus, Inc. | COM | 540,258 | $459.0K | 0.1% | 00.0% | Unchanged | History |
| UUnity Software Inc. | COM | 11,500 | $366.0K | 0.1% | +11,500 | New | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 250,000 | $365.0K | 0.1% | +250,000 | New | – |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 100,000 | $271.0K | <0.1% | 00.0% | Unchanged | – |
| ARBEArbe Robotics Ltd. | COM | 43,165 | $259.0K | <0.1% | 00.0% | Unchanged | History |
| OTMOOtonomo Technologies Ltd. | ORDINARY SHARES | 391,863 | $111.0K | <0.1% | 00.0% | Unchanged | History |
Options (9)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Tr46090E953 | PUT | $87.0M | – |
| NVIDIA Corporation67066G904 | CALL | – | $21.0M |
| Teva Pharmaceutical Inds Ltd881624909 | CALL | – | $17.8M |
| Unity Software Inc91332U901 | CALL | – | $11.7M |
| Generac Hldgs Inc368736904 | CALL | – | $6.34M |
| Sentinelone Inc81730H909 | CALL | – | $4.21M |
| Relmada Therapeutics Inc75955J952 | PUT | $3.44M | – |
| Dice Therapeutics Inc23345J954 | PUT | $3.04M | – |
| Altimmune Inc02155H950 | COM NEW | $1.28M | – |
Sold out since Q2 2022 (13)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 437,748 | $32.5M | 6.2% | – |
| FIVNFive9, Inc. | COM | 140,968 | $12.8M | 2.4% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 753,037 | $8.09M | 1.5% | History |
| METAMeta Platforms, Inc. | Stock | 50,000 | $8.06M | 1.5% | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 705,736 | $5.32M | 1.0% | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 3,291,135 | $2.90M | 0.5% | History |
| VVisa Inc. | Stock | 12,600 | $2.48M | 0.5% | History |
| ABNBAirbnb, Inc. | Stock | 27,700 | $2.47M | 0.5% | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 8,186 | $2.29M | 0.4% | – |
| AMDAdvanced Micro Devices Inc | Stock | 15,773 | $1.21M | 0.2% | History |
| KNTEKinnate Biopharma Inc. | COM | 91,673 | $1.16M | 0.2% | History |
| GNRCGenerac Holdings Inc. | Stock | 2,310 | $486.0K | 0.1% | History |
| VINCVincerx Pharma, Inc. | COM NEW | 70,467 | $93.0K | <0.1% | History |